Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
6.18
+0.09 (1.48%)
At close: Dec 20, 2024, 3:52 PM
6.14
-0.04 (-0.65%)
After-hours: Dec 20, 2024, 7:01 PM EST

Myomo Revenue

Myomo had revenue of $9.21M in the quarter ending September 30, 2024, with 81.27% growth. This brings the company's revenue in the last twelve months to $25.24M, up 36.23% year-over-year. In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth.

Revenue (ttm)
$25.24M
Revenue Growth
+36.23%
P/S Ratio
7.33
Revenue / Employee
$238,105
Employees
106
Market Cap
185.10M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.24M3.69M23.70%
Dec 31, 202215.56M1.70M12.26%
Dec 31, 202113.86M6.27M82.72%
Dec 31, 20207.58M3.75M97.60%
Dec 31, 20193.84M1.39M57.02%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 444.20M
Organigram Holdings 110.30M
Genfit 86.23M
MediWound 19.72M
Orchestra BioMed Holdings 2.65M
Quantum-Si incorporated 2.27M
Lyell Immunopharma 63.00K
Revenue Rankings